N1-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors

MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential

(2013) Darius. P. Zlotos et al.   JOURNAL OF MEDICINAL CHEMISTRY

Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors

(2012) D. P. Zlotos   CURRENT MEDICINAL CHEMISTRY

N-Acetyl-5-arylalkoxytryptamine Analogs: Probing the Melatonin Receptors for MT1-Selectivity

(2011) Christian Markl et al.   ARCHIV DER PHARMAZIE

Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: Synthesis, binding affinity and intrinsic activity for MT1 and MT2 melatonin receptors

(2011) Gilberto Spadoni et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Bivalent Dopamine D2Receptor Ligands: Synthesis and Binding Properties

(2011) Julia Kühhorn et al.   JOURNAL OF MEDICINAL CHEMISTRY

History and Biological Significance of GPCR Heteromerization in the Neuroendocrine System

(2011) Kenjiro Tadagaki et al.   NEUROENDOCRINOLOGY

2-[(1,3-Dihydro-2H-isoindol-2-yl)methyl]melatonin – a novel MT2-selective melatonin receptor antagonist

(2011) David Heckman et al.   MedChemComm

Synthesis and Biological Evaluation of Bivalent Ligands for the Cannabinoid 1 Receptor

(2010) Yanan Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

2-[(2,3-Dihydro-1H-indol-1-yl)methyl]melatonin Analogues: A Novel Class of MT2-Selective Melatonin Receptor Antagonists

(2009) Darius P. Zlotos et al.   JOURNAL OF MEDICINAL CHEMISTRY

Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

(2008) R Jockers et al.   BRITISH JOURNAL OF PHARMACOLOGY

How and why do GPCRs dimerize?

(2008) Vsevolod V. Gurevich et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The synthesis of bivalent 2β-carbomethoxy-3β-(3,4-dichlorophenyl)-8-heterobicyclo[3.2.1]octanes as probes for proximal binding sites on the dopamine and serotonin transporters

(2007) Peter C. Meltzer et al.   BIOORGANIC & MEDICINAL CHEMISTRY